Abstract
Background
Cancer remains the second leading cause of death worldwide, with nearly 10 million annual deaths. Chemotherapy, though essential, is highly complex and prone to dosing errors, interactions, and adverse effects. To improve safety and standardization, a Chemotherapy Order Template (COT) was developed based on NCCN guidelines.
Objective
To design, validate, and assess the reliability of a structured Chemotherapy Order Template that supports safe, accurate, and consistent chemotherapy prescribing in oncology settings.
Methods
The validation process included developing the template using NCCN (2025) guidelines, constructing a 22-item Likert-scale tool, obtaining multidisciplinary expert review, and conducting statistical testing using Pearson's correlation and Cronbach's alpha. A total of 54 experts participated.
Results
The expert panel comprised 46.30% physicians, 33.33% academicians, and 9.26% clinical pharmacists. The validation tool demonstrated excellent internal consistency with an overall Cronbach's alpha of 0.99. All 22 items showed significant positive correlations (p < 0.01), confirming strong construct validity. Expert feedback led to key enhancements in the COT.
Conclusion
The validated COT is a reliable and clinically relevant tool that improves safety, accuracy, and adherence to oncology guidelines in chemotherapy prescribing. Its structured design, based on expert consensus, promotes standardization, reduces medication errors, and supports coordinated, high-quality cancer care.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
